(2S,3S,4S,5R,6R)-6-{[(1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

• ChemBase编号: 174932
• 分子式: C25H31NO10
• 平均质量: 505.51434
• 单一同位素质量: 505.1947962
• SMILES: [C@H]1(O[C@H]([C@H]([C@@H]([C@@H]1O)O)O)C(=O)O)OC1[C@H]2[C@]34c5c(c(ccc5C[C@H]([C@@]3(CC1)O)N(CC=C)CC4)O)O2
• Canonical SMILES: C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(CC4)O[C@@H]2O[C@@H](C(=O)O)[C@H]([C@@H]([C@@H]2O)O)O)c(cc1)O)O
• InChI: InChI=1S/C25H31NO10/c1-2-8-26-9-7-24-15-11-3-4-12(27)19(15)35-21(24)13(5-6-25(24,33)14(26)10-11)34-23-18(30)16(28)17(29)20(36-23)22(31)32/h2-4,13-14,16-18,20-21,23,27-30,33H,1,5-10H2,(H,31,32)/t13?,14-,16+,17+,18-,20+,21+,23-,24+,25-/m1/s1
• InChIKey: LGMMRFSFVJQBQH-QYONGNPWSA-N

名称和登记号

名称

• IUPAC标准名: (2S,3S,4S,5R,6R)-6-{[(1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^1,^1^3.0^5,^1^7.0^7,^1^8]octadeca-7(18),8,10-trien-14-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
• IUPAC传统名: (2S,3S,4S,5R,6R)-6-{[(1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^1,^1^3.0^5,^1^7.0^7,^1^8]octadeca-7(18),8,10-trien-14-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
• 别名: (5α,6α))-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-yl β-D-Glucopyranosiduronic Acid; Naloxol-3-glucuronide; 6α-Naloxol 6-β-D-Glucuronide

登记号

• PubChem SID: 164230842
• PubChem CID: 57347639

理论计算性质

• Acid pKa: 2.804956
• 质子受体: 11
• 质子供体: 6
• LogD (pH = 5.5): -2.973187
• LogD (pH = 7.4): -2.9980223
• Log P: -2.9734213
• 摩尔折射率: 121.9003 cm^3
• 极化性: 48.669865 Å^3
• 极化表面积: 169.38 Å^2
• 可自由旋转的化学键: 5
• 里宾斯基五规则: false

详细说明

Toronto Research Chemicals - N284515

A metabolite of Naloxone (N285000). Narcotic antagonist.